Fund HoldingsAtlas Venture Life Science Advisors, LLC

Total Portfolio Value
$839.75M
Total Bought
$53.65M
Total Sold
$18.61M
Net Transaction
+$35.04M
Filing Period:
Securities
SharesValue ($K)
Q3 2023
Q4 2023
Change
Q3 2023
Q4 2023
Weight (%)
Change
Kymera Therapeutics, Inc.(KYMR)5,858,2625,858,262081,430149,15117.76%+67,722
Korro Bio, Inc.01,119,292+1,119,292053,6486.39%+53,648
Third Harmonic Bio, Inc.10,907,85910,907,859069,701119,65914.25%+49,958
Dyne Therapeutics, Inc.(DYN)9,885,4499,885,449088,574131,47615.66%+42,903
Disc Medicine, Inc.(IRON)2,745,3352,555,172-190,163128,976147,58717.58%+18,611
Aerovate Therapeutics, Inc.2,039,2492,039,249027,67346,1485.50%+18,476
Day One Biopharmaceuticals, Inc.
COM
7,608,3947,608,394093,355111,08313.23%+17,728
Spero Therapeutics, Inc.1,013,4381,013,43801,2261,4900.18%+263
Dianthus Therapeutics, Inc.(DNTH)236,979236,97903,2402,4650.29%-775
AvroBio, Inc.4,541,3814,541,38106,9946,1760.74%-817
Xilio Therapeutics, Inc.2,759,3442,759,34405,8221,5180.18%-4,305
Akero Therapeutics, Inc.359,251359,251018,1718,3891.00%-9,782
Vigil Neuroscience, Inc.5,836,8745,836,874031,46119,7292.35%-11,732
Ikena Oncology, Inc.5,018,1785,018,178021,7299,8861.18%-11,843
Generation Bio, Co.8,279,4848,279,484031,37913,6611.63%-17,718
Replimune Group, Inc.(REPL)2,098,3002,098,300035,90217,6892.11%-18,213
Page 1 of 1